http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96cd8005dfab848b49a1a79a7f477b33
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Sridhara |
| name | Rajeshwari Sridhara |
| given-name | Rajeshwari |
| organization-name | US Food and Drug Administration, Silver Spring, MD, USA Authors' Affiliations: 1Office of Hematology and Oncology Drug Products, Office of New Drugs,2Office of Biostatistics, Office of Translational Sciences, 3Office of Clinical Pharmacology and Office of Translational Sciences, and 4Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration Division of Drug Oncology Products, Office of Oncology Drug Products, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Center for Drug Evaluation and Research, U.S. Food and Drug Administration, White Oak, Maryland. a Division of Biometrics 1 , HFD-710 , Office of Biostatistics, The Food and Drug Administration , Rockville, Maryland, USA; d Division of Biometrics 1 , HFD-710 , Office of Biostatistics, The Food and Drug Administration , 5600 Fishers Lane, Rockville, MD, 20857, USA Office of Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland Authors' Affiliations: 1CDER/OTS/OB/DBV, U.S. Food and Drug Administration, Silver Spring; 2Biostatistics Research Branch, National Institute of Allergy and Infectious Disease, NIH, Bethesda, Maryland; and 3Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota Authors' Affiliations: 1Office of Hematology and Oncology Drug Products, 2Study Endpoints and Label Development, Office of New Drugs, 3Office of Clinical Pharmacology, and 4Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland Chana Weinstock, MD; Laura L. Fernandes, PhD; Marc Theoret, MD; Shenghui Tang, PhD; Rajeshwari Sridhara, PhD; Julia A. Beaver, MD; and Richard Pazdur, MD, US Food and Drug Administration, Silver Spring, MD 5Office of Biostatistics, CDER, U.S. Food and Drug Administration, Silver Spring, Maryland. All authors: US Food and Drug Administration, Silver Spring, MD. Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA Edward S. Kim, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; Suanna S. Bruinooge, Caroline Schenkel, and Richard L. Schilsky, ASCO, Alexandria, VA; Samantha Roberts, Marina Kozak, Jeff Allen, and Ellen Sigal, Friends of Cancer Research; Samantha Roberts, Genentech, Washington, DC; Gwynn Ison, Julia A. Beaver, Rajeshwari Sridhara, and Tatiana M. Prowell, US Food and Drug Administration, Silver Spring; Thomas S. Uldrick and Andrea M. Denicoff, National Cancer Institute, Bethesda, MD;... Center for Drug Evaluation and Research, U.S. Food and Drug Administration Silver Spring, MD, USA U.S. Food and Drug Administration, White Oak, Maryland. Center for Drug Evaluation and Research, US Food and Drug Administration, White Oak, Maryland Center for Drug Evaluation and Research, U.S. Food and Drug, Administration, Silver Spring, Maryland. Center for Drug Evaluation and Research U.S. Food and Drug Administration, Silver Spring, Maryland, USA Authors' Affiliation: Food and Drug Administration, Silver Spring, Maryland US Food and Drug Administration, White Oak, MD Office of Translational Sciences, US Food and Drug Administration, Silver Spring, Maryland 1Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland. Authors' Affiliation: Division of Drug Oncology Products, Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland From the Eastern Cooperative Oncology Group Breast Cancer Committee, Albert Einstein Comprehensive Cancer Center, Montefiore Medical Center, Bronx, NY; the Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, NY; Northwestern University School of Medicine, Chicago, IL; and the University of Maryland Greenebaum Cancer Center, Baltimore, MD. a Division of Drug Oncology Products, Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Office of Biostatistics, Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring MD USA Authors' Affiliation: Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA All authors: Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD. Office of Oncology Drug Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 3Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. 2Office of Biostatistics, Office of Translational Sciences; Authors' Affiliations: 1Office of Hematology and Oncology Products, Office of New Drugs; 2Office of Biostatistics; 3Office of Clinical Pharmacology; and 4Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland Center for Drug Evaluation and Research, U.S. Food and Drug, Administration, White Oak, Maryland. 3Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. 3US Food and Drug Administration, Oncology Center of Excellence, Silver Spring, Maryland. Authors' Affiliations: 1Division of Biometrics V/Office of Biostatistics/Office of Translational Sciences and 2Office of Hematology and Oncology Products/Office of New Drugs, Center for Drug Evaluation Research, U.S. Food and Drug Administration, Silver Spring; and 3Biostatistics Research Branch, National Institute of Allergy and Infectious Disease, NIH, Bethesda, Maryland Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD 1Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA Division of Biometrics V, Office of Biostatistics, Office of Translational Sciences, Center of Drug Evaluation and Research U.S. Food and Drug Administration Silver Spring Maryland USA 2U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland 2Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. Authors' Affiliation: Division of Drug Oncology Products, Office of Oncology Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland Authors' Affiliations: 1Office of Hematology and Oncology Products, Office of New Drugs, 2Office of Biostatistics, 3Office of Clinical Pharmacology, and 4Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland Division of Oncology Drug Products, Center for Drug Evaluation and Research, United States Food and Drug Administration, Rockville, Maryland 4Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland Authors' Affiliations: 1Office of Hematology and Oncology Products, Office of New Drugs, 2Office of Biostatistics, 3Office of Clinical Pharmacology, 4Office of New Drug Quality Assessment, and Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Maryland. Authors' Affiliation: Division of Oncology Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland Authors' Affiliation: Division of Oncology Drug Products (HFD-150), Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland 2Office of Biostatistics, Authors' Affiliation: Division of Drug Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland Authors' Affiliations: 1CDER/OTS/OB/DBV, and 2CDER/OND/OHOP/DOP-1, U.S. Food and Drug Administration, Silver Spring, Maryland Authors' Affiliations: 1Office of Hematology and Oncology Products, 2Office of Biostatistics, 3Office of Clinical Pharmacology, and 4Office of Pharmaceutical Science, Office of New Drug Quality Assessment, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland US Food and Drug Administration Silver Spring Maryland USA Office of Biostatistics, U. S. Food and Drug Administration Silver Spring, MD, USA All authors: Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, White Oak, MD. Office of Biostatistics, Center for Drug Evaluation and Research, FDA, MD, USA US Food and Drug Administration, Silver Spring, MD Division of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland, USA b Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA 1Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. 2Office of Biostatistics, U.S. Food and Drug Administration, Silver Spring, Maryland. Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. |
Incoming Links
Total number of triples: 203.